NGeneBio Co., Ltd. engages in the research and development of diagnostic products related to cancer. Its products include next generation sequencing based testing kit for in vitro diagnosis (IVD), anti-cancer companion diagnostics, prenatal diagnosis kit (IVD) for rare diseases and analysis software. The company was founded on October 30, 2015 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company